Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2008
12/03/2008EP1380592B1 Cell surface layer-binding protein and utilization thereof
12/03/2008EP1280398B1 Stress-related potassium channel proteins and their uses in plants
12/03/2008EP1149163B1 Chromatographic method for purification of albumin
12/03/2008EP1097233B1 Growth differentiation factor promoter and uses therefor
12/03/2008EP1043395B1 Novel g protein-coupled receptor proteins
12/03/2008EP0606217B2 Ctl4a receptor, fusion proteins containing it and uses thereof
12/03/2008CN101316931A 抗病植物 Plant Disease
12/03/2008CN101316930A T-cell adhesion molecule and antibody directed against the molecule
12/03/2008CN101316929A Novel gene SMS 37
12/03/2008CN101316927A FcRn受体的用途 FcRn receptor usage
12/03/2008CN101316862A Production of recombinant collagen like proteins
12/03/2008CN101316861A IL-17A and IL-17F antagonists and methods of using the same
12/03/2008CN101316860A Production and use of highly functional, highly branched or hyperbranched polylysines
12/03/2008CN101316583A Treatment of cancer with specific rxr agonists
12/03/2008CN101314617A Novel snake venom polypeptide, preparation and application thereof
12/03/2008CN101314616A Hemorrhagic bacillus coli of intestine 0157:H7 shiga toxin IIB epitope peptide and uses thereof
12/03/2008CN101314615A Viral capsid mosaic protein HPV16 L1-P<D>, preparation method and application thereof
12/03/2008CN100439510C Process for preparing low molecular peptide and amino acid by biological enzymolysis of pig blood haematoglobin
12/03/2008CN100439500C Mouse model of hipatitis B virus gene positioning integration to result in liver cell callcer
12/03/2008CN100439499C Neutrokine-alpha and Neutrokine-alpha splice variant
12/03/2008CN100439492C Host microorganisms
12/03/2008CN100439398C Human monoclonal antibodies to dendritic cells
12/03/2008CN100439397C Crystallization of IGF-1
12/03/2008CN100439396C Polypeptide of ramification of ciliary nerves nutrilite for curing obesity
12/03/2008CN100439395C Compositions and methods for therapy and diagnosis of ovarian cancer
12/03/2008CN100439394C Pharmaceutical use for secreted bacterial effector proteins
12/03/2008CN100439391C Process for producing hydrophobic polypeptides, proteins or peptides
12/03/2008CN100438920C Cancer gene therapeutic drug
12/03/2008CN100438905C Stable liquid formulations of botulinum toxin
12/02/2008US7460961 N-TRADD active site and uses thereof
12/02/2008US7459613 Plants and seeds of corn variety LH307
12/02/2008US7459611 Plants and seeds of corn variety I286350
12/02/2008US7459609 Soybean cultivar 6035184
12/02/2008US7459605 Transforming a plant cell with a nucleic acid sequence that encodes the acquired resistance polypeptide, regenerating a plant from the transformed plant cell; resistance to fungal pathogens
12/02/2008US7459604 Methods for generating resistance against CGMMV in plants
12/02/2008US7459602 for breast, kidney, ovary and stomach cancers; comprises a probe having the nucleotide sequence complementary to mRNA transcribed from the human protooncogene (HCCR-1)
12/02/2008US7459600 Isolation, selection and propagation of animal transgenic stem cells
12/02/2008US7459544 Comprises nucleotide sequences coding b lymphocyte antigens for use as tool in prevention and treatment of cell proliferative disorders; immunotherapy
12/02/2008US7459543 Modulators of antiestrogen pharmacology
12/02/2008US7459541 Fusion polypeptide comprising a collagen-binding domain and an epithelial cell proliferation-modulating domain for use as tool in regenerative medicine and tissue repair
12/02/2008US7459540 Fibroblast growth factor-like polypeptides
12/02/2008US7459539 Composition for modulating activity of transport protein; for use in tumor diagnosis and treatment; antitumor/anticarcinogenic agents
12/02/2008US7459537 Anti-lymphotoxin-β receptor antibodies as anti-tumor agents
12/02/2008US7459535 Method of forming a polymerized hemoglobin solution from stabilized hemoglobin
12/02/2008US7459534 Inactivation resistant factor VIII
12/02/2008US7459533 Interleukin-10 homolog for use as a therapeutic tool in treatment and prevention of inflammatory, autoimmue and cell proliferative disorders
12/02/2008US7459532 Transient receptor potential cation channel for use in identifying modulators for prevention and treatment of cell proliferative and nervous system disorders
12/02/2008US7459531 Glycosylated polypeptide of given amino acid sequence; treatment of genetic diseases such as muscular dystrophy and cystic fibrosis
12/02/2008US7459530 Tango 405 polypeptides and uses thereof
12/02/2008US7459528 DNA sequences encoding tumor necrosis factor receptors; recombinant expression vectors
12/02/2008US7459527 Variants of human bone morphogenetic proteins and other cysteine knot cytokine proteins with improved properties, including increased expression yield, expression in absence of a pro-domain, increased solubility, increased specific activity, altered receptor, co-receptor, inhibitor specificity
12/02/2008US7459526 Method for synthesizing peptides, peptide mimetics and proteins
12/02/2008US7459525 Glycosylated protein for use in the treatment of blood disorders
12/02/2008US7459524 Polypeptide of given sequence; use in vaccines
12/02/2008US7459523 Antiinflammatory ligand for use in prevention and treatment of intestinal ischemia, salmonellosis and/or sepsis
12/02/2008US7459522 Peptide dimers as agonists of the erythropoietin (EPO) receptor, and associated methods of synthesis and use
12/02/2008US7459441 Remedies for dry eye and diseases associated with dry eye
12/02/2008US7459440 Ocular tear growth factor-like protein
12/02/2008US7459439 Treating cutaneous microbial infections such as Propionibacterium acnes by administering a granulysin peptide that is modified to increase hydrophobicity
12/02/2008US7459438 sustained relese of saratin polypeptide to prevent platelet adhesion after vascular injury; thrombosis and restenosis inhibitor
12/02/2008US7459434 Peptide interacting with anti-apoptotic proteins of the Bcl-2 family
12/02/2008US7459433 Lowering circulating free fatty acid levels, reducing body mass, maintaining weight loss, and treating obesity-related diseases and disorders
12/02/2008US7459432 adminsteration of Peptide YY or an agonist to a overweight subject, or having obesity related disorders, results in decreased food intake, caloric intake, appetite, and an alteration in energy metabolism
12/02/2008US7459431 Recombinant gelatin-like proteins for use as plasma expanders
12/02/2008US7459427 Reducing glucagon production by administering a corticotrophin releasing factor receptor 2 antagonist, especially a Urocortin III analog; treating high body temperature, appetite dysfunction, congestive heart failure, vascular disease, stress and anxiety.
12/02/2008US7459426 Methods of using IL-1 antagonists to treat autoinflammatory disease
12/02/2008US7459310 DNA encoding protein of given amino acid sequence; culturing transformant comprising vector; screening for ligands; cancer and reproductive treatment
12/02/2008US7459309 Isolated polypeptide deletion mutants of survival of motor neuron-interacting protein 1
12/02/2008US7459308 Nucleic acid molecule encoding a CLASP-2 transmembrane protein
12/02/2008US7459300 Expression vector comprising nucleotide sequences coding metastatic tumor element for use in diagnosis, prevention and treatment of renal and cell proliferative disorders
12/02/2008US7459298 Nucleic acid of given sequence; recombinant vectors; use in preparation of pharmaceutical kits
12/02/2008US7459297 Attenuated viral polymerase for use as diagnostic tool in detecting inhibitory agents for treatment of viral diseases; enzyme inhibitors and viricides
12/02/2008US7459296 Hepatitis C virus NS3 helicase subdomain I
12/02/2008US7459293 Polypeptide of given sequence; stimulating immune system and proliferation or development of hematopoietic cells
12/02/2008US7459292 Nucleotide sequence encoding polypeptide; ligand binding to neuromedin; central nervous system and psychological disorders
12/02/2008US7459291 Chordin-like molecules and uses thereof
12/02/2008US7459287 Screening agents which modulate formation of FANCD2-containing foci; cell expressing polynucleotide comprising DNA sequence encoding protein
12/02/2008US7459282 Use of c-Jun or c-Jun activating agents such as UV or c-Jun N-terminal kinases (JNKs) for treating cancer
12/02/2008US7459279 Determining if substance is ligand by contacting with cell and measuring modulation of intracellular calcium level; treatment of central nervous system and psychiatric disorders
12/02/2008US7459277 Mammalian T1R3 sweet taste receptors
12/02/2008US7459275 Sequencing of surface immobilized polymers utilizing microfluorescence detection
12/02/2008US7459270 Which is incapable of reproduction within human cell lines; for treatment of human immunodeficency virus
12/02/2008US7459172 Drug encapsulation; hollow tubes; drug delivery
12/02/2008US7459165 isolated polypeptide consisting of the amino acid sequence set forth as SEQ ID NO:4 from which the signal peptide sequence set forth as SEQ ID NO:38 is deleted; Pseudomonas aeruginosa infection
12/02/2008US7459164 Composition for therapeutic and cosmetic botulinum toxin
12/02/2008US7459163 Infectious DNA as a vaccine against west nile and other flaviviruses
12/02/2008US7459162 Avian pandemic; immunogens; antibodies; immunology
12/02/2008US7459160 Chimeric flaviviruses
12/02/2008US7459158 Can be used to vaccinate a mammal against specific self or non-self antigens
12/02/2008US7459156 Antibodies that mimic actions of neurotrophins
12/02/2008US7459153 Viral vectors for gene therapy
12/02/2008CA2475116C Polypeptides involved in the expression of resistance to glycopeptides antibiotics
12/02/2008CA2409771C Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes
12/02/2008CA2385348C Promoter for regulating expression of foreign genes
12/02/2008CA2348377C Human orphan g protein-coupled receptors
12/02/2008CA2315716C Interactive dental restorative network
12/02/2008CA2303395C Treatment of obesity
12/02/2008CA2284170C Identification of agents for use in the treatment of alzheimer's disease
12/02/2008CA2282843C Purification of von willebrand factor by cation exchange chromatography
12/02/2008CA2282841C A method of purifying factor viii/vwf-complex by means of cation exchange chromatography